Compound Evidence File
#EC-2026-0928
Hyaluronic acid
Filed under Peptides. The bureau holds 200 laboratory returns for this compound from 90 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
90 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 4 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 4 | 10.0 | 9.9 | 10.0 | 8 Dec 2025 | 22 Jun 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 4 | 10.0 | 9.9 | 10.0 | 2 Jul 2026 | 20 Aug 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 3 | 10.0 | 9.9 | 10.0 | 10 Apr 2026 | 2 Jul 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 3 | 10.0 | 9.9 | 10.0 | 14 Dec 2025 | 9 Jul 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 3 | 10.0 | 10.0 | 10.0 | 19 Dec 2025 | 25 May 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 3 | 10.0 | 10.0 | 10.0 | 4 Apr 2026 | 12 Jul 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 3 | 10.0 | 9.9 | 10.0 | 8 Mar 2026 | 1 Jun 2026 |
| Bulk Peptide WholesaleCASE #VI-2026-0319 | A | 2 | 10.0 | 10.0 | 10.0 | 8 Jul 2025 | 24 May 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 2 | 10.0 | 10.0 | 10.0 | 3 Apr 2026 | 24 Jun 2026 |
| Orbitrex PeptidesCASE #VI-2026-0812 | X | 1 | 10.0 | 10.0 | 10.0 | 13 Jun 2025 | 13 Jun 2025 |
| The Naughty NeedleCASE #VI-2026-0432 | X | 1 | 10.0 | 10.0 | 10.0 | 28 Mar 2025 | 28 Mar 2025 |
| HomopeptideCASE #VI-2026-0760 | A | 5 | 9.9 | 9.9 | 10.0 | 25 May 2026 | 25 May 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 4 | 9.9 | 9.9 | 10.0 | 8 Dec 2025 | 7 Jul 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 4 | 9.9 | 9.9 | 10.0 | 7 Mar 2026 | 28 Jul 2026 |
| AsymchemCASE #VI-2026-0091 | A | 4 | 9.9 | 9.9 | 10.0 | 10 Feb 2026 | 23 Jul 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 3 | 9.9 | 9.9 | 10.0 | 22 Mar 2026 | 3 Jun 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 3 | 9.9 | 9.9 | 10.0 | 2 Nov 2025 | 10 Apr 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 3 | 9.9 | 9.9 | 9.9 | 13 Dec 2025 | 3 Jun 2026 |
| SinoPepCASE #VI-2026-0387 | A | 3 | 9.9 | 9.9 | 10.0 | 16 May 2026 | 6 Aug 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 2 | 9.9 | 9.9 | 10.0 | 28 May 2026 | 21 Jun 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 2 | 9.9 | 9.9 | 10.0 | 20 May 2026 | 15 Jun 2026 |
| BachemCASE #VI-2026-0314 | A | 2 | 9.9 | 9.9 | 10.0 | 19 Jun 2026 | 27 Jun 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 2 | 9.9 | 9.9 | 9.9 | 22 May 2026 | 8 Jun 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 2 | 9.9 | 9.9 | 10.0 | 20 Mar 2026 | 20 Apr 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 2 | 9.9 | 9.9 | 9.9 | 14 May 2026 | 17 Aug 2026 |
| Aavant ResearchCASE #VI-2026-0831 | X | 1 | 9.9 | 9.9 | 9.9 | 2 Jul 2025 | 2 Jul 2025 |
| Pure Tested PeptidesCASE #VI-2026-0225 | X | 1 | 9.9 | 9.9 | 9.9 | 7 May 2025 | 7 May 2025 |
| Risynth BioCASE #VI-2026-0672 | X | 1 | 9.8 | 9.8 | 9.8 | 7 May 2025 | 7 May 2025 |
| HkRoidsCASE #VI-2026-0784 | X | 1 | 9.0 | 9.0 | 9.0 | 13 Jun 2025 | 13 Jun 2025 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 6 | 8.9 | 7.8 | 10.0 | 21 May 2026 | 21 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 6 | 8.8 | 7.7 | 10.0 | 24 May 2026 | 24 May 2026 |
| Yiwu Aozuo Trading CoCASE #VI-2026-0798 | X | 2 | 8.8 | 8.3 | 9.3 | 2 Jul 2025 | 20 May 2026 |
| Eros PeptidesCASE #VI-2026-0918 | X | 1 | 8.6 | 8.6 | 8.6 | 16 Mar 2025 | 16 Mar 2025 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 8 | 8.5 | 6.8 | 10.0 | 21 May 2026 | 21 May 2026 |
| Xingtai Jiachuang TechnologyCASE #VI-2026-0712 | X | 1 | 8.5 | 8.5 | 8.5 | 6 May 2025 | 6 May 2025 |
| Huaian Hanyou PeptideCASE #VI-2026-0297 | X | 1 | 8.4 | 8.4 | 8.4 | 2 Apr 2025 | 2 Apr 2025 |
| Shenzhen Loga Tech LG LOGACASE #VI-2026-0920 | X | 1 | 8.4 | 8.4 | 8.4 | 17 Dec 2024 | 17 Dec 2024 |
| Shandong Aishi BiotechnologyCASE #VI-2026-0308 | X | 2 | 8.3 | 8.3 | 8.3 | 27 Feb 2025 | 17 May 2026 |
| EHZ PeptidesCASE #VI-2026-0296 | X | 1 | 8.3 | 8.3 | 8.3 | 27 Feb 2025 | 27 Feb 2025 |
| OmegAminoCASE #VI-2026-0014 | X | 1 | 8.3 | 8.3 | 8.3 | 6 May 2025 | 6 May 2025 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 2 | 8.1 | 8.1 | 8.2 | 24 May 2026 | 24 May 2026 |
| BfflinkCASE #VI-2026-0212 | X | 1 | 8.1 | 8.1 | 8.1 | 14 Jan 2025 | 14 Jan 2025 |
| UWA Elite PeptidesCASE #VI-2026-0130 | X | 1 | 8.1 | 8.1 | 8.1 | 14 Jan 2025 | 14 Jan 2025 |
| Anlv BiotechnologyCASE #VI-2026-0110 | X | 1 | 7.7 | 7.7 | 7.7 | 7 May 2025 | 7 May 2025 |
| Elite Research USACASE #VI-2026-0267 | X | 2 | 7.4 | 5.8 | 9.1 | 25 Apr 2025 | 23 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 2 | 7.3 | 6.5 | 8.2 | 24 May 2026 | 24 May 2026 |
| Xian Yihang TechnologyCASE #VI-2026-0656 | X | 1 | 7.3 | 7.3 | 7.3 | 2 Apr 2025 | 2 Apr 2025 |
| Pure RawzCASE #VI-2026-0767 | X | 2 | 7.2 | 6.5 | 7.9 | 25 Apr 2025 | 25 May 2026 |
| Zztai PeptideCASE #VI-2026-0192 | X | 1 | 7.2 | 7.2 | 7.2 | 24 Apr 2025 | 24 Apr 2025 |
| Nuscience PeptidesCASE #VI-2026-0554 | X | 1 | 7.2 | 7.2 | 7.2 | 16 Mar 2025 | 16 Mar 2025 |
| HazelCASE #VI-2026-0392 | X | 1 | 7.0 | 7.0 | 7.0 | 21 May 2025 | 21 May 2025 |
| Atomik LabzCASE #VI-2026-0327 | X | 2 | 6.8 | 4.8 | 8.9 | 13 Feb 2025 | 20 May 2026 |
| SRY LabsCASE #VI-2026-0657 | X | 1 | 6.8 | 6.8 | 6.8 | 21 May 2025 | 21 May 2025 |
| HXNetCASE #VI-2026-0061 | X | 7 | 6.7 | 5.8 | 7.8 | 2 Jul 2025 | 24 May 2026 |
| TSC Top Supplements ChinaCASE #VI-2026-0523 | X | 6 | 6.7 | 5.4 | 8.4 | 6 May 2025 | 26 Jan 2026 |
| Shanghai OuDaXin New Material Technology CenterCASE #VI-2026-0498 | E | 3 | 6.4 | 4.0 | 9.6 | 13 Feb 2025 | 20 May 2026 |
| Paramount PeptidesCASE #VI-2026-0550 | X | 5 | 6.3 | 3.8 | 8.0 | 2 Apr 2025 | 21 May 2026 |
| Eternal PeptidesCASE #VI-2026-0842 | X | 2 | 6.3 | 5.6 | 7.1 | 3 Jun 2025 | 24 May 2026 |
| Amino AmigosCASE #VI-2026-0061 | X | 1 | 6.3 | 6.3 | 6.3 | 27 Feb 2025 | 27 Feb 2025 |
| Regenerative ResearchCASE #VI-2026-0349 | X | 1 | 6.2 | 6.2 | 6.2 | 28 Mar 2025 | 28 Mar 2025 |
| Peptide-SCASE #VI-2026-0111 | X | 12 | 6.1 | 3.7 | 8.4 | 21 May 2025 | 24 May 2026 |
| LSPLCASE #VI-2026-0523 | X | 4 | 6.0 | 2.7 | 7.9 | 7 May 2025 | 21 May 2026 |
| Mix PeptidesCASE #VI-2026-0699 | X | 2 | 6.0 | 5.5 | 6.5 | 24 Apr 2025 | 21 May 2026 |
| Changan District Sheng Peptide TradingCASE #VI-2026-0341 | X | 1 | 6.0 | 6.0 | 6.0 | 20 Jun 2025 | 20 Jun 2025 |
| Amplified AminoCASE #VI-2026-0748 | X | 1 | 6.0 | 6.0 | 6.0 | 24 Apr 2025 | 24 Apr 2025 |
| HybiopeptidesCASE #VI-2026-0305 | X | 1 | 6.0 | 6.0 | 6.0 | 2 Jul 2025 | 2 Jul 2025 |
| ScienceCASE #VI-2026-0636 | X | 1 | 5.8 | 5.8 | 5.8 | 25 Apr 2025 | 25 Apr 2025 |
| YB PeptideCASE #VI-2026-0813 | X | 1 | 5.5 | 5.5 | 5.5 | 2 Apr 2025 | 2 Apr 2025 |
| Accelerate LabsCASE #VI-2026-0686 | X | 2 | 5.4 | 4.0 | 6.8 | 8 Jul 2025 | 20 May 2026 |
| Hangzhou Mandy BiotechnologyCASE #VI-2026-0695 | X | 1 | 5.4 | 5.4 | 5.4 | 17 Dec 2024 | 17 Dec 2024 |
| ZhuoYan labCASE #VI-2026-0902 | X | 1 | 5.4 | 5.4 | 5.4 | 21 May 2025 | 21 May 2025 |
| CellupepCASE #VI-2026-0888 | X | 1 | 5.3 | 5.3 | 5.3 | 7 May 2025 | 7 May 2025 |
| Peptides 4 ResearchCASE #VI-2026-0511 | X | 2 | 4.8 | 4.1 | 5.4 | 6 May 2025 | 23 May 2026 |
| Shanghai BaojuCASE #VI-2026-0233 | X | 1 | 4.8 | 4.8 | 4.8 | 11 Jun 2025 | 11 Jun 2025 |
| Haikou Mingheng BiotechnologyCASE #VI-2026-0126 | X | 1 | 4.8 | 4.8 | 4.8 | 3 Jun 2025 | 3 Jun 2025 |
| Shanghai Wibson Biotechnology WBSCASE #VI-2026-0214 | X | 1 | 4.7 | 4.7 | 4.7 | 21 May 2025 | 21 May 2025 |
| Qingdao VitaConin International TradingCASE #VI-2026-0504 | X | 1 | 4.6 | 4.6 | 4.6 | 13 Jun 2025 | 13 Jun 2025 |
| Suaway Lab ResearchCASE #VI-2026-0488 | X | 3 | 3.9 | 2.4 | 5.0 | 27 Feb 2025 | 23 May 2026 |
| Forever Young PharmacyCASE #VI-2026-0654 | X | 2 | 3.5 | 3.1 | 3.8 | 2 Jul 2025 | 23 May 2026 |
| PeptiLab ResearchCASE #VI-2026-0267 | X | 1 | 3.1 | 3.1 | 3.1 | 3 Jul 2025 | 3 Jul 2025 |
| Dragon PharmaCASE #VI-2026-0519 | X | 1 | 3.0 | 3.0 | 3.0 | 3 Jun 2025 | 3 Jun 2025 |
| Peptide ArkCASE #VI-2026-0350 | X | 1 | 2.6 | 2.6 | 2.6 | 21 May 2025 | 21 May 2025 |
| Peptides For SaleCASE #VI-2026-0614 | X | 1 | 1.9 | 1.9 | 1.9 | 11 Jun 2025 | 11 Jun 2025 |
| Advanced Technology and IndustrialCASE #VI-2026-0133 | X | 1 | 1.3 | 1.3 | 1.3 | 17 Dec 2024 | 17 Dec 2024 |
| Zhuoyue BiotechnologyCASE #VI-2026-0632 | X | 1 | 0.3 | 0.3 | 0.3 | 2 Jul 2025 | 2 Jul 2025 |
| PepKitsCASE #VI-2026-0320 | X | 1 | 0.2 | 0.2 | 0.2 | 7 May 2025 | 7 May 2025 |
| Marvel PeptideCASE #VI-2026-0507 | X | 1 | 0.0 | 0.0 | 0.0 | 24 Apr 2025 | 24 Apr 2025 |
| Hebei Chengtong TechnologyCASE #VI-2026-0520 | X | 1 | 0.0 | 0.0 | 0.0 | 8 Jul 2025 | 8 Jul 2025 |
| Lejian Biotech PeptideCASE #VI-2026-0746 | X | 1 | 0.0 | 0.0 | 0.0 | 6 May 2025 | 6 May 2025 |
Open any subject to view the batch-level evidence for Hyaluronic acid alone.